Netherlands - Lipid Modifying Medicine Use
Since 2014, Netherlands Lipid Modifying Medicine Use rose 3.2% year on year. With 136.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 8 comparing other countries in Lipid Modifying Medicine Use. Netherlands is overtaken by Czech Republic, which was ranked number 7 at 140.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Canada with 128.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark topped the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is +3.5% versus 2018. United Kingdom, Belgium and Norway respectively ranked number 2, 3 and 4 in this ranking. Lithuania recorded the best 5 years average growth at +15% per year, while Slovakia was the worst growing country at -7% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 136.20 |
| 2018 | 132.80 |
| 2017 | 129.70 |
| 2016 | 125.80 |
| 2015 | 120.10 |
How does Netherlands rank in Lipid Modifying Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
| 2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
| 7 |
#7
Czech Republic
|
140 | 2019 | +3.7 % | +4.5 % | View data | |
| 8 |
#8
Netherlands
|
136 | 2019 | +2.6 % | +3.2 % | View data | |
| 9 |
#9
Canada
|
129 | 2019 | +2.0 % | +5.0 % | View data | |